An overview of the regulatory regime governing human genetic resources (HGR) in China. This note highlights the features of the regulation on HGR and lays out the penalties on the violations of the legal requirements. It also provides practical guidance for pharmaceutical and medical device companies doing business in China on HGR compliance management and risk prevention.